Literature DB >> 30153355

Cell blocks in cytopathology: An update.

Aruna Nambirajan1, Deepali Jain1.   

Abstract

The cell block (CB) offers many advantages over other cytological preparations, particularly for immunocytochemical and molecular testing. However, inconsistent cellularity remains the most common reason for dissatisfaction among cytopathologists. In recent years, there has been a surge in the demand for CBs imposed by the increasing number of minimally invasive procedures performed to obtain material for diagnostic, prognostic and predictive purposes from advanced stage cancer patients. However, routine preparation of CBs significantly increases laboratory work load, operating cost and sample turn-around time. The objectives of our review were to: (a) identify scenarios where a CB is likely to improve diagnostic yield; (b) optimise CB preparatory methods; and (c) understand the factors influencing the success and validity of ancillary testing on various types of CBs. We performed an extensive literature search on CBs in cytology on internet search engines using the following keywords: cell block, cytoblock, cytology, cytopathology, methods, preparation, fixatives, diagnostic yield, ancillary and molecular studies. New CB methods, improvisations of previous CB methods, their utility for diagnosis, immunocytochemistry and molecular testing, and role in predictive biomarker testing are discussed in this review. CBs of good quality and cellularity outperform other cytology preparations in their reliability and versatility for ancillary testing. With many CB methods described in the literature, each with specific advantages and limitations, laboratories may choose to use one or more of the methods depending upon their infrastructure, expertise and workload.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  Cellient; ancillary tests; cell block; cytology; update

Mesh:

Substances:

Year:  2018        PMID: 30153355     DOI: 10.1111/cyt.12627

Source DB:  PubMed          Journal:  Cytopathology        ISSN: 0956-5507            Impact factor:   2.073


  14 in total

1.  Evaluating Mismatch Repair/Microsatellite Instability Status Using Cytology Effusion Specimens to Determine Eligibility for Immunotherapy.

Authors:  Elizabeth M Jacobi; Gene Landon; Russell R Broaddus; Sinchita Roy-Chowdhuri
Journal:  Arch Pathol Lab Med       Date:  2020-03-30       Impact factor: 5.534

Review 2.  Immunocytochemistry for predictive biomarker testing in lung cancer cytology.

Authors:  Deepali Jain; Aruna Nambirajan; Alain Borczuk; Gang Chen; Yuko Minami; Andre L Moreira; Noriko Motoi; Mauro Papotti; Natasha Rekhtman; Prudence A Russell; Spasenija Savic Prince; Yasushi Yatabe; Lukas Bubendorf
Journal:  Cancer Cytopathol       Date:  2019-05-03       Impact factor: 5.284

3.  Evaluating Mismatch Repair/Microsatellite Instability Status Using Cytology Effusion Specimens to Determine Eligibility for Immunotherapy.

Authors:  Elizabeth M Jacobi; Gene Landon; Russell R Broaddus; Sinchita Roy-Chowdhuri
Journal:  Arch Pathol Lab Med       Date:  2021-01-01       Impact factor: 5.686

Review 4.  The Diagnostic Dilemma of Urothelial Tissue Fragments in Urinary Tract Cytology Specimens.

Authors:  Derek B Allison; M Lisa Zhang; Poonam Vohra; Christopher J VandenBussche
Journal:  Diagnostics (Basel)       Date:  2022-04-08

Review 5.  Processing and Reporting of Cytology Specimens from Mediastinal Lymph Nodes Collected using Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration: A State-of-the-Art Review.

Authors:  Inderpaul Singh Sehgal; Nalini Gupta; Sahajal Dhooria; Ashutosh Nath Aggarwal; Karan Madan; Deepali Jain; Parikshaa Gupta; Neha Kawatra Madan; Arvind Rajwanshi; Ritesh Agarwal
Journal:  J Cytol       Date:  2020-04-02       Impact factor: 1.000

Review 6.  CellBlockistry: Chemistry and art of cell-block making - A detailed review of various historical options with recent advances.

Authors:  Vinod B Shidham
Journal:  Cytojournal       Date:  2019-06-28       Impact factor: 2.091

7.  Formalin fixation for optimal concordance of programmed death-ligand 1 immunostaining between cytologic and histologic specimens from patients with non-small cell lung cancer.

Authors:  Bregje M Koomen; Jose van der Starre-Gaal; Judith M Vonk; Jan H von der Thüsen; Jacqueline J C van der Meij; Kim Monkhorst; Stefan M Willems; Wim Timens; Nils A 't Hart
Journal:  Cancer Cytopathol       Date:  2020-10-27       Impact factor: 5.284

8.  Indian Academy of Cytologists Guidelines for Collection, Preparation, Interpretation, and Reporting of Serous Effusion Fluid Samples.

Authors:  Radhika Srinivasan; Bharat Rekhi; Arvind Rajwanshi; Saleem Pathuthara; Sandeep Mathur; Deepali Jain; Nalini Gupta; Upasana Gautam; Naresh Rai; Vijay Shrawan Nijhawan; Venkat Iyer; Pranab Dey; Prabal Deb; Dev Prasoon
Journal:  J Cytol       Date:  2019-12-23       Impact factor: 1.000

Review 9.  INSM1, a Novel Biomarker for Detection of Neuroendocrine Neoplasms: Cytopathologists' View.

Authors:  Zahra Maleki; Akash Nadella; Mohnish Nadella; Gopi Patel; Shivni Patel; Ivana Kholová
Journal:  Diagnostics (Basel)       Date:  2021-11-23

Review 10.  PD-L1 and beyond: Immuno-oncology in cytopathology.

Authors:  Antonino Iaccarino; Maria Salatiello; Ilaria Migliatico; Caterina De Luca; Gianluca Gragnano; Maria Russo; Claudio Bellevicine; Umberto Malapelle; Giancarlo Troncone; Elena Vigliar
Journal:  Cytopathology       Date:  2021-05-06       Impact factor: 2.073

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.